Title |
Retinal oxygen extraction in individuals with type 1 diabetes with no or mild diabetic retinopathy
|
---|---|
Published in |
Diabetologia, May 2017
|
DOI | 10.1007/s00125-017-4309-0 |
Pubmed ID | |
Authors |
Klemens Fondi, Piotr A. Wozniak, Kinga Howorka, Ahmed M. Bata, Gerold C. Aschinger, Alina Popa-Cherecheanu, Katarzyna J. Witkowska, Anton Hommer, Doreen Schmidl, René M. Werkmeister, Gerhard Garhöfer, Leopold Schmetterer |
Abstract |
The aim of this study was to compare retinal oxygen extraction in individuals with diabetes with no or mild non-proliferative diabetic retinopathy and healthy age- and sex-matched volunteers. A total of 24 participants with type 1 diabetes and 24 healthy age- and sex-matched volunteers were included in this cross-sectional study. Retinal oxygen extraction was measured by combining total retinal blood flow measurements using a custom-built bi-directional Doppler optical coherence tomography system with measurements of oxygen saturation using spectroscopic reflectometry. Based on previously published mathematical modelling, the oxygen content in retinal vessels and total retinal oxygen extraction were calculated. Total retinal blood flow was higher in diabetic participants (46.4 ± 7.4 μl/min) than in healthy volunteers (40.4 ± 5.3 μl/min, p = 0.002 between groups). Oxygen content in retinal arteries was comparable between the two groups, but oxygen content in retinal veins was higher in participants with diabetes (0.15 ± 0.02 ml O2/ml) compared with healthy control participants (0.13 ± 0.02 ml O2/ml, p < 0.001). As such, the arteriovenous oxygen difference and total retinal oxygen extraction were reduced in participants with diabetes compared with healthy volunteers (total retinal oxygen extraction 1.40 ± 0.44 vs 1.70 ± 0.47 μl O2/min, respectively, p = 0.03). Our data indicate early retinal hypoxia in individuals with type 1 diabetes with no or mild diabetic retinopathy as compared with healthy control individuals. Further studies are required to fully understand the potential of the technique in risk stratification and treatment monitoring. ClinicalTrials.gov NCT01843114. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 20% |
Cabo Verde | 1 | 10% |
United Kingdom | 1 | 10% |
France | 1 | 10% |
Germany | 1 | 10% |
Norway | 1 | 10% |
Unknown | 3 | 30% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 90% |
Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 30 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 20% |
Student > Bachelor | 3 | 10% |
Student > Doctoral Student | 2 | 7% |
Student > Ph. D. Student | 2 | 7% |
Student > Master | 1 | 3% |
Other | 3 | 10% |
Unknown | 13 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 20% |
Engineering | 6 | 20% |
Physics and Astronomy | 1 | 3% |
Agricultural and Biological Sciences | 1 | 3% |
Neuroscience | 1 | 3% |
Other | 1 | 3% |
Unknown | 14 | 47% |